MAPT and type 1 diabetes mellitus: Tau phosphorylation levels (AT8 and pSer396) in the cortex and hippocampus were significantly reduced, while nonphosphorylated Tau levels (Tau-1) were increased in T1DM rats treated with BTMP compared with control rats (Supplementary Figure 7).